No abstract

No abstract

A multitude of natural products from plant extracts have been tested for their ability to inhibit the progression of several diseases including cancer. A novel approach of evaluating plant (rice) callus suspension cultures for anticancer activity is reported. The ability of different dilutions of rice callus suspension cultures to inhibit growth of two human cancer cell lines was tested employing varying cell numbers and different incubation times. A crystal violet assay was performed to assess cell viability of the cancer cell lines. Furthermore, microscopic analysis was carried out to determine the effect of the rice callus culture on the morphology of the cancer cells. Rice callus suspension cultures significantly inhibited the growth of human cancer and renal cell lines at densities of 5000 and 10000 cells/mL when incubated for 72 and 96 h. Rice callus suspension culture was more efficient than paclitaxel (Taxol®) and etoposide in selectively killing human colon and renal cancer cell lines compared with a control cell line (human lung fibroblasts). The use of plant callus suspension cultures is a novel approach for inhibiting the growth of cancer cells, which will lead to the development of new agents for selectively killing cancer cells.

Several studies have demonstrated the potential uses of extracellular vesicles (EVs) for liquid biopsy‐based diagnostic tests and therapeutic applications; however, clinical use of EVs presents a challenge as many currently‐available EV isolation methods have limitations related to efficiency, purity, and complexity of the methods. Moreover, many EV isolation methods do not perform efficiently in all biofluids due to their differential physicochemical properties. Thus, there continues to be a need for novel EV isolation methods that are simple, robust, non‐toxic, and/or clinically‐amenable. Here we demonstrate a rapid and efficient method for small extracellular vesicle (sEV) isolation that uses chitosan, a linear cationic polyelectrolyte polysaccharide that exhibits biocompatibility, non‐immunogenicity, biodegradability, and low toxicity. Chitosan‐precipitated material was characterized using Western blotting, nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and relevant proteomic‐based gene ontology analyses. We find that chitosan facilitates the isolation of sEVs from multiple biofluids, including cell culture‐conditioned media, human urine, plasma and saliva. Overall, our data support the potential for chitosan to isolate a population of sEVs from a variety of biofluids and may have the potential to be a clinically amenable sEV isolation method.

No abstract